SCHEMBL2531361

SCHEMBL2531361

CC1(C)Cc2cc(Cl)cc(C(=O)O)c2NC1c1cccc(N2CCN(c3ccc(Cl)cc3)CC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
ADAMTS5 Q9UNA0 2/20 0.36
MMP14 P50281 1/20 0.36
LMNA P02545 4/20 0.36
MAPT P10636 4/20 0.36
HTR1A P08908 1/20 0.36
HTR7 P34969 1/20 0.36
TSHR P16473 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TMEM97 Q5BJF2 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35
ALOX12 P18054 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SERPINE1 P05121 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2531526 0.94 ALDH1A1 (0.39) ALDH1A1TDP1MEN1KMT2ALMNA
SCHEMBL2532199 0.92 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AADAMTS5LMNA
SCHEMBL2534968 0.92 CYP2C19 (0.43) ALDH1A1MEN1KMT2AMAPT
SCHEMBL2535155 0.90 CYP1A2 (0.40) ALDH1A1MEN1KMT2AADAMTS5MMP14
SCHEMBL2529380 0.89 ALDH1A1 (0.40) ALDH1A1TDP1MEN1KMT2ALMNA
SCHEMBL2533411 0.87 BCL2 (0.40) ALDH1A1MEN1KMT2AADAMTS5MMP14
SCHEMBL2566040 0.85 JAK2 (0.41) HTR1AHTR7TMEM97SIGMAR1CA12
SCHEMBL14331314 0.84 CYP2C19 (0.41)
SCHEMBL2530166 0.84 SIRT6 (0.40) ALDH1A1MEN1KMT2AMAPTTSHR
SCHEMBL2530622 0.83 F10 (0.35) ALDH1A1TDP1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 ALDH1A1 552/4885TDP1 1853/4885MEN1 353/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 ALDH1A1 552/4885TDP1 1853/4885MEN1 353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.